Literature DB >> 11843640

Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides?

Reinhard Dummer1, Jivko Kamarashev, Werner Kempf, Andreas C Häffner, Monika Hess-Schmid, Günter Burg.   

Abstract

OBJECTIVE: To evaluate the clinical and prognostic features in primary cutaneous CD8+ T-cell lymphomas, which are rare and considered to be aggressive cutaneous lymphoproliferative disorders.
DESIGN: Single-center retrospective study.
SETTING: Lymphoma clinic (referral center) of a university hospital. PATIENTS: Three patients presented with CD8+ cutaneous lymphoma characterized by a patchlike pattern and hyperpigmentation.
RESULTS: Histological analysis revealed a CD3+, CD8+ small-cell infiltrate showing a remarkable affinity to the dermoepidermal junction zone. Clonality for the T-cell receptor gamma chain was detected by polymerase chain reaction followed by denaturing gradient gel electrophoresis. The clinical presentation lasted several years (6 and 9 years, respectively) before the correct diagnosis was made. Treatment with nontoxic approaches (UV-B and local steroids) was successful. Aggressive clinical behavior was not observed.
CONCLUSIONS: Our 3 cases of junctional CD8+ cutaneous T-cell lymphomas were characterized by hyperpigmentation and nonaggressive clinical behavior. This type of lymphoma, which can be considered a CD8+ mycosis fungoides variant, must be distinguished from other types of cutaneous CD8+ lymphomas so that overtreatment can be avoided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843640     DOI: 10.1001/archderm.138.2.199

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.

Authors:  Joon Lee; You Jin Yang; Jung-In Kim; Ji-Hye Park; Won-Serk Kim
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

2.  [Cutaneous lymphoma].

Authors:  M Beyeler; G Burg; R Dummer
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

3.  CD30 expression and proliferative fraction in nontransformed mycosis fungoides.

Authors:  James T Edinger; Beth Z Clark; Brian E Pucevich; Larisa J Geskin; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

4.  Cutaneous pseudolymphomatous drug eruption secondary to supplemental flaxseed oil.

Authors:  Emma L Larson; Christian Scheufele; Bethany R Rohr; Kord Honda; Kevin Cooper
Journal:  JAAD Case Rep       Date:  2022-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.